↓ Skip to main content

Different Doses of Fingolimod in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Overview of attention for article published in Frontiers in Pharmacology, May 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Different Doses of Fingolimod in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Published in
Frontiers in Pharmacology, May 2021
DOI 10.3389/fphar.2021.621856
Pubmed ID
Authors

Xin Wu, Tao Xue, Zilan Wang, Zhouqing Chen, Xuwei Zhang, Wei Zhang, Zhong Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 11%
Student > Doctoral Student 3 11%
Lecturer 2 7%
Researcher 2 7%
Student > Bachelor 2 7%
Other 3 11%
Unknown 12 44%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 15%
Biochemistry, Genetics and Molecular Biology 2 7%
Medicine and Dentistry 2 7%
Neuroscience 2 7%
Psychology 1 4%
Other 3 11%
Unknown 13 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 June 2021.
All research outputs
#14,267,331
of 23,308,124 outputs
Outputs from Frontiers in Pharmacology
#4,499
of 16,753 outputs
Outputs of similar age
#218,809
of 443,665 outputs
Outputs of similar age from Frontiers in Pharmacology
#249
of 958 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,753 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,665 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 958 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.